Fast Access to HIV Prevention and Opioid Treatment

PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study

['FUNDING_R01'] · BOSTON MEDICAL CENTER · NIH-11118902

This project helps people who inject drugs quickly get access to medicines that prevent HIV and treat opioid use disorder.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorBOSTON MEDICAL CENTER (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-11118902 on ClinicalTrials.gov

What this research studies

We know that HIV and opioid use disorder often happen together, and we want to offer a complete approach to help. This project aims to make it easier and faster for individuals to start taking HIV prevention medication (PrEP) and medication for opioid use disorder (MOUD). We will provide HIV self-testing at the beginning and offer support from a peer recovery coach for six months to help people stay on track.

Who could benefit from this research

Good fit: Ideal candidates are persons who inject drugs and are at risk for HIV or have opioid use disorder.

Not a fit: Patients who are not at risk for HIV due to injecting drugs or who do not have opioid use disorder would not directly benefit from this specific program.

Why it matters

Potential benefit: If successful, this project could significantly reduce new HIV infections and help more people manage opioid use disorder.

How similar studies have performed: Previous research, including a randomized controlled trial, has shown that peer-delivered support can be effective in reducing substance use and that this type of intervention is feasible.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.